(Q39211871)

10 September 2017

Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study (English)

1 reference

10 September 2017

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Lin Fritschi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rachel E. Neale

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

5

Penelope M Webb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Pik Fang Kho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jonathan Fawcett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Harvey Risch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

5 November 2016

1 reference

10 September 2017

Cancer Causes & Control

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1457-1464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10552-016-0824-4

4 June 2020

exact match

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Cancer survival and prevalence in Australia: period estimates from 1982 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Demographics and epidemiology of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Jewish ethnicity and pancreatic cancer mortality in a large U.S. cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Case-control study of aspirin use and risk of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Aspirin use and pancreatic cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Statins and pancreatic cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Statin use and risk of pancreatic cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Surgical management in patients with pancreatic cancer: a Queensland perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Celecoxib for the prevention of colorectal adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Celecoxib for the prevention of sporadic colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Statin use and the risk of pancreatic cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Cigarette smoking and pancreatic cancer risk: More to the story than just pack-years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0824-4

Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/JCB.22523

Identifiers

DOI

10.1007/S10552-016-0824-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27817122%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference